Innovating Works

ALIRI

Desconocido
MASS2: Modern Au-based Surfaces and Secondary ionisation for Mass Spectrometry Imaging of Small molecules ALIRI FRANCE SAS participó en un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Matrix-assisted laser desorption/ionisation (MALDI) mass spectrometry imaging (MSI) is increasingly used for clinical application. Based on...
2022-05-19 - 2024-05-31 | Financiado
CAPSTONE: Training experts in antigen processing to deliver new drug prototypes for cancer and autoimmune dis... ALIRI FRANCE SAS participó en un H2020: H2020-MSCA-ITN-2020 Current trends in immunotherapy are to develop immuno-modulatory small molecules for intracellular targets for single therapy or combination...
2020-09-03 - 2024-12-31 | Financiado
ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ALIRI FRANCE SAS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado
CaSR Biomedicine: Calcium Sensing Receptor CaSR Therapeutics for Non Communicable Diseases ALIRI FRANCE SAS participó en un H2020: H2020-MSCA-ITN-2015 The calcium sensing receptor (CaSR) is a class C Gprotein-coupled receptor that plays a pivotal role in systemic calcium metabolism by regul...
2015-07-17 - 2020-02-29 | Financiado
HIPAD: High Density Peptide MicroArrays and high throughput label free detection of peptides modification... ALIRI FRANCE SAS participó en un FP7: Proteins are extremely malleable building blocks of life involved in all aspects of biology. Many diseases are caused by proteins aberration...
Financiado
CARTARDIS: Identification and validation of novel pharmaceutical drug targets for cardiovascular disease ALIRI FRANCE SAS participó en un FP7: "Cardiovascular disease (CVD) is one of the major diseases in Europe and the Western world, killing over 2 million people per year in Europe...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.